Active Ingredient(s): Rilpivirine
FDA Approved: * May 20, 2011
Pharm Company: * TIBOTEC
Category: HIV / AIDS

Rilpivirine, sold under the brand names Edurant and Rekambys, is a medication, developed by Tibotec, used for the treatment of HIV/AIDS.[5][6] It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs such as efavirenz.[7][8] Contents 1 Medical uses 1.1 Available forms 2 Contraindications and interactions 3... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Edurant TMC;25
Edurant 25 mg Oral Tablet
NDC: 59676-278
Janssen Products, Lp